|Articles|February 15, 2002
Info+: Industry News
Author(s)BioPharm International Editors
Industry news on investors, software validation guidance, mergers and aquisitions, new drugs on the market, a Science Advisory Board that helps vendors understand life-science needs, a new FDA inspection paradigm, and licensing priorities.
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
